286 related articles for article (PubMed ID: 15338190)
1. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
Choi BR; Ahn MJ; Lee WS; Kim TH; Bae SC; Jun JB
Rheumatol Int; 2005 May; 25(4):311-3. PubMed ID: 15338190
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate treatment and mortality in rheumatoid arthritis.
Slot O
Lancet; 2002 Oct; 360(9339):1095; author reply 1097-8. PubMed ID: 12384008
[No Abstract] [Full Text] [Related]
3. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Furst DE
Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
[No Abstract] [Full Text] [Related]
4. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
5. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
6. Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine.
Bensen W; Bensen W
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S95-101. PubMed ID: 10589366
[TBL] [Abstract][Full Text] [Related]
7. [Combined basic therapy of rheumatoid arthritis with methotrexate and plaquenil].
Sergiets NA; Erov NK
Ter Arkh; 2009; 81(6):34-7. PubMed ID: 19663190
[TBL] [Abstract][Full Text] [Related]
8. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
[No Abstract] [Full Text] [Related]
9. Orbital myositis in a rheumatoid arthritis patient during etanercept treatment.
Caramaschi P; Biasi D; Carletto A; Bambara LM
Clin Exp Rheumatol; 2003; 21(1):136-7. PubMed ID: 12673906
[No Abstract] [Full Text] [Related]
10. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
11. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
12. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
O'Dell JR
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
[TBL] [Abstract][Full Text] [Related]
13. An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre.
Jobanputra P; Hunter M; Clark D; Lambert CM; Hurst NP
Br J Rheumatol; 1995 Oct; 34(10):971-5. PubMed ID: 7582706
[TBL] [Abstract][Full Text] [Related]
14. [The effect of comedication with folic or folinic acid on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a randomized, double blind, placebo controlled study of 48 weeks].
Jansen TL; Spoorenberg A; Houtman PM; van Roon EN
Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2168; author reply 2168. PubMed ID: 12474559
[No Abstract] [Full Text] [Related]
15. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
16. Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study.
Koh KT; Teh CL; Cheah CK; Ling GR; Yong MC; Hong HC; Gun SC
Reumatismo; 2016 Sep; 68(2):90-6. PubMed ID: 27608797
[TBL] [Abstract][Full Text] [Related]
17. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
18. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate: vital new information about a middle aged drug.
Giannini EH
J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
[No Abstract] [Full Text] [Related]
20. Multifocal inflammatory demyelination in a patient with rheumatoid arthritis and treatment complications.
Lu JQ; Ringrose J; Gross D; Emery D; Blevins G; Power C
J Neurol Sci; 2016 Aug; 367():305-7. PubMed ID: 27423608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
